Tristan E. Knight MD, FRCPC (@t_e_knight) 's Twitter Profile
Tristan E. Knight MD, FRCPC

@t_e_knight

Peds Hem/Onc/BMT Doc @SeattleChildren, Clinical Assistant Professor @UWMedicine. Runner 26.2 x8. Enthusiastic Nerd! He/Him. Views my own/not medical advice.🇨🇦

ID: 877937741048270848

linkhttps://www.seattlechildrens.org/directory/tristan-elliot-knight# calendar_today22-06-2017 17:14:03

1,1K Tweet

1,1K Followers

864 Following

Tristan E. Knight MD, FRCPC (@t_e_knight) 's Twitter Profile Photo

Cross posting here - full thread over on… Threads lol Super excited to report that our newest article has now been published! “No impact of CD34+ cell dose on outcome among children undergoing... threads.net/@tknighty/post…

Rémy Duléry (@remydulery) 's Twitter Profile Photo

Nonrestrictive diet is not inferior to traditional protective diet during the neutropenic phase after HSCT (auto or allo). Hopefully, all centers will soon stop using restrictive diets, an unnecessary burden for patients’ quality of life. 👉ashpublications.org/bloodadvances/… #bmtsm

Nonrestrictive diet is not inferior to traditional protective diet during the neutropenic phase after HSCT (auto or allo).

Hopefully, all centers will soon stop using restrictive diets, an unnecessary burden for patients’ quality of life. 

👉ashpublications.org/bloodadvances/… #bmtsm
Rahul Banerjee, MD, FACP (@rahulbanerjeemd) 's Twitter Profile Photo

1/ Great to see version 1.0 out! ASTCT effort led by Tristan E. Knight MD, FRCPC et al to provide a living central repository of 🇺🇸 BMT/CT fellowships (both peds & adults) 👇 Link below - if you know of anyone who hasn't yet submitted their program, let them know! astct.org/practice/fello…

1/ Great to see version 1.0 out!

<a href="/ASTCT/">ASTCT</a> effort led by <a href="/t_e_knight/">Tristan E. Knight MD, FRCPC</a> et al to provide a living central repository of 🇺🇸 BMT/CT fellowships (both peds &amp; adults) 👇

Link below - if you know of anyone who hasn't yet submitted their program, let them know!
astct.org/practice/fello…
Rahul Banerjee, MD, FACP (@rahulbanerjeemd) 's Twitter Profile Photo

2/ While we work on building this ASTCT database out, the source of this is still available in Supplement to our survey of recent participants of BMT/CT fellowships (cc Amar Kelkar, MD, MPH, FACP Miki Nishitani Theodora Anagnostou, MD Aaron Logan, MD, PhD, MPhil @BldCancerDoc) Link here: astctjournal.org/article/S2666-…

2/ While we work on building this <a href="/ASTCT/">ASTCT</a> database out, the source of this is still available in Supplement to our survey of recent participants of BMT/CT fellowships (cc <a href="/amarkelkar/">Amar Kelkar, MD, MPH, FACP</a> <a href="/mikinishitanimd/">Miki Nishitani</a>  <a href="/TheodoraAnagno1/">Theodora Anagnostou, MD</a> <a href="/hemedoc/">Aaron Logan, MD, PhD, MPhil</a> @BldCancerDoc)

Link here:
astctjournal.org/article/S2666-…
Tristan E. Knight MD, FRCPC (@t_e_knight) 's Twitter Profile Photo

🚨🚨🚨Attention peds/adult heme/onc fellows! Ever considered a bone marrow transplant/cell therapy fellowship, but weren't sure where to find a training program? ASTCT’s fellowship database is now live! New programs being added daily! Check it out! astct.org/practice/fello…

Oncology Data Advisor (@oncdata) 's Twitter Profile Photo

Did you hear about the #FDA approval of #inotuzumab ozagamicin for #pediatric patients with R/R CD22-positive B-cell precursor #ALL? Hear insights from OncData Board member Dr. Tristan Knight (Tristan E. Knight MD, FRCPC) in this article, and comment your thoughts below! oncdata.com/news/inotuzuma…

Did you hear about the #FDA approval of #inotuzumab ozagamicin for #pediatric patients with R/R CD22-positive B-cell precursor #ALL? Hear insights from OncData Board member Dr. Tristan Knight (<a href="/t_e_knight/">Tristan E. Knight MD, FRCPC</a>) in this article, and comment your thoughts below!

oncdata.com/news/inotuzuma…
Oncology Data Advisor (@oncdata) 's Twitter Profile Photo

The #FDA granted accelerated #approval to #ponatinib with #chemotherapy for adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic #leukemia (#Ph+ #ALL). Learn more about the approval and the #trial that led to it here: oncdata.com/news/ponatinib…

Oncology Data Advisor (@oncdata) 's Twitter Profile Photo

Did you hear about this week's accelerated #FDA #approval of #ponatinib + chemo for Ph+ acute lymphoblastic #leukemia (#ALL)? Read more about the approval and insights from Tristan E. Knight MD, FRCPC in this article, and share your thoughts in the comments! oncdata.com/news/ponatinib… #leuksm

Did you hear about this week's accelerated #FDA #approval of #ponatinib + chemo for Ph+ acute lymphoblastic #leukemia (#ALL)? Read more about the approval and insights from <a href="/t_e_knight/">Tristan E. Knight MD, FRCPC</a> in this article, and share your thoughts in the comments!

oncdata.com/news/ponatinib…

#leuksm
Oncology Data Advisor (@oncdata) 's Twitter Profile Photo

ICYMI: Last month, OncData held a live panel with Richa Thakur, MD, Tristan E. Knight MD, FRCPC, and Joseph Kalis in honor of Acute Myeloid #Leukemia (#AML) Awareness Day. Watch the video now to hear their insights on evolving treatment directions! oncdata.com/news/acute-mye… #AMLAwarenessDay

ICYMI: Last month, OncData held a live panel with <a href="/RichaThakurMD/">Richa Thakur, MD</a>, <a href="/t_e_knight/">Tristan E. Knight MD, FRCPC</a>, and Joseph Kalis in honor of Acute Myeloid #Leukemia (#AML) Awareness Day. Watch the video now to hear their insights on evolving treatment directions! 

oncdata.com/news/acute-mye…

#AMLAwarenessDay
POGO (@pogo4kids) 's Twitter Profile Photo

Thanks to a #POGOGuideline, slushies provide an evidence-based intervention to prevent and reduce mouth sores in a fun and tasty way. Check out the impact this POGO guideline is having around the world: bit.ly/3KufRn8. #ChildhoodCancer #Mucositis

Thanks to a #POGOGuideline, slushies provide an evidence-based intervention to prevent and reduce mouth sores in a fun and tasty way. Check out the impact this POGO guideline is having around the world: bit.ly/3KufRn8. #ChildhoodCancer #Mucositis
Oncology Data Advisor (@oncdata) 's Twitter Profile Photo

The #FDA has approved #blinatumomab as consolidation for CD19-positive, Philadelphia #chromosome–negative B-cell precursor acute lymphoblastic #leukemia (Ph-negative #BCP #ALL). Learn more about the #approval and the trial that led to it here: oncdata.com/blinatumomab-a…

The #FDA has approved #blinatumomab as consolidation for CD19-positive, Philadelphia #chromosome–negative B-cell precursor acute lymphoblastic #leukemia (Ph-negative #BCP #ALL). Learn more about the #approval and the trial that led to it here: oncdata.com/blinatumomab-a…
Oncology Data Advisor (@oncdata) 's Twitter Profile Photo

August is #SummerSunSafetyMonth, a time to shed light on the importance of protection from #sun damage while still enjoying the #outdoors. Hear tips from Tristan E. Knight MD, FRCPC and Matthew Hadfield in this video! oncdata.com/summer-sun-saf… #skincancer #SPF #sunsafety #sunburn #summer #melanoma

August is #SummerSunSafetyMonth, a time to shed light on the importance of protection from #sun damage while still enjoying the #outdoors. 

Hear tips from <a href="/t_e_knight/">Tristan E. Knight MD, FRCPC</a> and <a href="/mhadfield30/">Matthew Hadfield</a> in this video! oncdata.com/summer-sun-saf…

#skincancer #SPF #sunsafety #sunburn #summer #melanoma
Blood Advances (@bloodadvances) 's Twitter Profile Photo

PBSC and BM donors had no differences in incidence rates for myeloid, lymphoid, other cancers, autoimmune diseases, or thrombotic events. ow.ly/5j0w50SX2GE #clinicaltrialsandobservations #healthservicesandoutcomes #hematopoiesisandstemcells #transplantation

PBSC and BM donors had no differences in incidence rates for myeloid, lymphoid, other cancers, autoimmune diseases, or thrombotic events. ow.ly/5j0w50SX2GE #clinicaltrialsandobservations #healthservicesandoutcomes #hematopoiesisandstemcells #transplantation
Oncology Data Advisor (@oncdata) 's Twitter Profile Photo

The #FDA has approved #axatilimab-csfr for chronic graft-versus-host #disease (#cGVHD). Learn more about this #approval and the trial that led to it, including an expert perspective from Tristan E. Knight MD, FRCPC here: oncdata.com/axatilimab-csf…

The #FDA has approved #axatilimab-csfr for chronic graft-versus-host #disease (#cGVHD).

Learn more about this #approval and the trial that led to it, including an expert perspective from <a href="/t_e_knight/">Tristan E. Knight MD, FRCPC</a> here: oncdata.com/axatilimab-csf…
Oncology Data Advisor (@oncdata) 's Twitter Profile Photo

In honor of #ChildhoodCancerAwareness Month this September, Dr. Tristan E. Knight MD, FRCPC curated a primer on #pediatric cancers, including the story behind the significance of this month! Check it out here: oncdata.com/childhood-canc…

In honor of #ChildhoodCancerAwareness Month this September, Dr. <a href="/t_e_knight/">Tristan E. Knight MD, FRCPC</a> curated a primer on #pediatric cancers, including the story behind the significance of this month! 

Check it out here: oncdata.com/childhood-canc…